

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | purine nucleobase biosynthetic process (GO:0009113) | 6.76604931 |
| 2 | nucleobase biosynthetic process (GO:0046112) | 6.25260620 |
| 3 | folic acid metabolic process (GO:0046655) | 5.84248687 |
| 4 | ribosome assembly (GO:0042255) | 5.60824346 |
| 5 | ribosome biogenesis (GO:0042254) | 5.04634761 |
| 6 | folic acid transport (GO:0015884) | 5.04142754 |
| 7 | mitotic metaphase plate congression (GO:0007080) | 4.77156807 |
| 8 | vitamin transmembrane transport (GO:0035461) | 4.76982913 |
| 9 | formation of translation preinitiation complex (GO:0001731) | 4.60459137 |
| 10 | mannose metabolic process (GO:0006013) | 4.40264337 |
| 11 | DNA replication checkpoint (GO:0000076) | 4.37178512 |
| 12 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.29318470 |
| 13 | lung-associated mesenchyme development (GO:0060484) | 4.24125399 |
| 14 | rRNA modification (GO:0000154) | 4.20406554 |
| 15 | regulation of spindle organization (GO:0090224) | 4.18999165 |
| 16 | proteasome assembly (GO:0043248) | 4.15911279 |
| 17 | regulation of translation in response to stress (GO:0043555) | 3.97783910 |
| 18 | termination of RNA polymerase III transcription (GO:0006386) | 3.89072660 |
| 19 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.89072660 |
| 20 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.86430299 |
| 21 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.80034899 |
| 22 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.78921451 |
| 23 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.78808294 |
| 24 | spliceosomal snRNP assembly (GO:0000387) | 3.75300874 |
| 25 | maturation of SSU-rRNA (GO:0030490) | 3.74603157 |
| 26 | positive regulation of chromosome segregation (GO:0051984) | 3.71422609 |
| 27 | regulation of translational termination (GO:0006449) | 3.71398804 |
| 28 | NIK/NF-kappaB signaling (GO:0038061) | 3.68727747 |
| 29 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.66980480 |
| 30 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.66775020 |
| 31 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.65114805 |
| 32 | glycine metabolic process (GO:0006544) | 3.64825263 |
| 33 | amino sugar catabolic process (GO:0046348) | 3.63590134 |
| 34 | blastocyst development (GO:0001824) | 3.61560985 |
| 35 | modified amino acid transport (GO:0072337) | 3.61276093 |
| 36 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.61059277 |
| 37 | amino acid salvage (GO:0043102) | 3.56934281 |
| 38 | L-methionine salvage (GO:0071267) | 3.56934281 |
| 39 | L-methionine biosynthetic process (GO:0071265) | 3.56934281 |
| 40 | 7-methylguanosine mRNA capping (GO:0006370) | 3.54936383 |
| 41 | rRNA processing (GO:0006364) | 3.53821701 |
| 42 | DNA replication initiation (GO:0006270) | 3.53637294 |
| 43 | DNA deamination (GO:0045006) | 3.52341110 |
| 44 | pantothenate metabolic process (GO:0015939) | 3.51074569 |
| 45 | transcription from RNA polymerase I promoter (GO:0006360) | 3.49902614 |
| 46 | pseudouridine synthesis (GO:0001522) | 3.48871052 |
| 47 | regulation of mitotic spindle organization (GO:0060236) | 3.47373998 |
| 48 | metaphase plate congression (GO:0051310) | 3.46562336 |
| 49 | response to peptidoglycan (GO:0032494) | 3.46146465 |
| 50 | rRNA metabolic process (GO:0016072) | 3.43304436 |
| 51 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.43296095 |
| 52 | 7-methylguanosine RNA capping (GO:0009452) | 3.41417833 |
| 53 | RNA capping (GO:0036260) | 3.41417833 |
| 54 | L-serine metabolic process (GO:0006563) | 3.41017110 |
| 55 | protein localization to kinetochore (GO:0034501) | 3.40621312 |
| 56 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.39237750 |
| 57 | termination of RNA polymerase I transcription (GO:0006363) | 3.38077535 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 3.35471876 |
| 59 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.32494862 |
| 60 | regulation of gene silencing by miRNA (GO:0060964) | 3.32494862 |
| 61 | regulation of gene silencing by RNA (GO:0060966) | 3.32494862 |
| 62 | GMP metabolic process (GO:0046037) | 3.32225679 |
| 63 | histone arginine methylation (GO:0034969) | 3.31175867 |
| 64 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.30636912 |
| 65 | negative regulation of ligase activity (GO:0051352) | 3.30636912 |
| 66 | lysosome organization (GO:0007040) | 3.28886920 |
| 67 | lytic vacuole organization (GO:0080171) | 3.28886920 |
| 68 | methionine biosynthetic process (GO:0009086) | 3.28844173 |
| 69 | mitotic nuclear envelope disassembly (GO:0007077) | 3.28047038 |
| 70 | intestinal epithelial cell development (GO:0060576) | 3.27519147 |
| 71 | amyloid precursor protein catabolic process (GO:0042987) | 3.25613325 |
| 72 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.23603523 |
| 73 | mitotic sister chromatid segregation (GO:0000070) | 3.23521574 |
| 74 | aspartate family amino acid biosynthetic process (GO:0009067) | 3.19981796 |
| 75 | autophagic vacuole assembly (GO:0000045) | 3.19508058 |
| 76 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.18224822 |
| 77 | negative regulation of chromosome segregation (GO:0051985) | 3.17797826 |
| 78 | ribosomal large subunit biogenesis (GO:0042273) | 3.17740969 |
| 79 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.17067392 |
| 80 | glycosphingolipid catabolic process (GO:0046479) | 3.16865109 |
| 81 | positive regulation of ligase activity (GO:0051351) | 3.14861964 |
| 82 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.12525563 |
| 83 | barbed-end actin filament capping (GO:0051016) | 3.12424269 |
| 84 | regulation of G0 to G1 transition (GO:0070316) | 3.12357658 |
| 85 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 3.10371482 |
| 86 | rRNA methylation (GO:0031167) | 3.10032043 |
| 87 | regulation of chromosome segregation (GO:0051983) | 3.08056780 |
| 88 | hyaluronan catabolic process (GO:0030214) | 3.07985569 |
| 89 | negative regulation of translational initiation (GO:0045947) | 3.07853827 |
| 90 | transcription from mitochondrial promoter (GO:0006390) | 3.07848706 |
| 91 | mitotic spindle checkpoint (GO:0071174) | 3.07553215 |
| 92 | maturation of 5.8S rRNA (GO:0000460) | 3.05711395 |
| 93 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.05536506 |
| 94 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.05096458 |
| 95 | IMP biosynthetic process (GO:0006188) | 3.04713257 |
| 96 | UV protection (GO:0009650) | 3.04236147 |
| 97 | nuclear envelope disassembly (GO:0051081) | 3.03722087 |
| 98 | membrane disassembly (GO:0030397) | 3.03722087 |
| 99 | mitotic spindle assembly checkpoint (GO:0007094) | 3.03478616 |
| 100 | spindle checkpoint (GO:0031577) | 3.03437203 |
| 101 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.03269350 |
| 102 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.03144456 |
| 103 | negative regulation of sister chromatid segregation (GO:0033046) | 3.03144456 |
| 104 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.03144456 |
| 105 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.03144456 |
| 106 | methionine metabolic process (GO:0006555) | 3.01752478 |
| 107 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.01636534 |
| 108 | positive regulation of viral transcription (GO:0050434) | 3.01232741 |
| 109 | negative regulation of macroautophagy (GO:0016242) | 2.98146486 |
| 110 | N-acetylneuraminate metabolic process (GO:0006054) | 2.97963953 |
| 111 | mitotic G1/S transition checkpoint (GO:0044819) | 2.96361717 |
| 112 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.91816768 |
| 113 | spindle assembly checkpoint (GO:0071173) | 2.91329740 |
| 114 | regulation of mast cell degranulation (GO:0043304) | 2.91282478 |
| 115 | cullin deneddylation (GO:0010388) | 2.91271334 |
| 116 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.89705106 |
| 117 | cellular component biogenesis (GO:0044085) | 2.89282974 |
| 118 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.88765242 |
| 119 | neutrophil activation involved in immune response (GO:0002283) | 2.88055764 |
| 120 | adhesion of symbiont to host (GO:0044406) | 2.86958652 |
| 121 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86830621 |
| 122 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.85097800 |
| 123 | cellular response to arsenic-containing substance (GO:0071243) | 2.83464011 |
| 124 | low-density lipoprotein particle clearance (GO:0034383) | 2.82800240 |
| 125 | adhesion of symbiont to host cell (GO:0044650) | 2.82065813 |
| 126 | virion attachment to host cell (GO:0019062) | 2.82065813 |
| 127 | glycolipid catabolic process (GO:0019377) | 2.81359820 |
| 128 | response to thyroid hormone (GO:0097066) | 2.78082132 |
| 129 | regulation of cholesterol storage (GO:0010885) | 2.77448343 |
| 130 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.75920545 |
| 131 | regulation of leukocyte degranulation (GO:0043300) | 2.73378643 |
| 132 | negative regulation of granulocyte differentiation (GO:0030853) | 2.72971681 |
| 133 | tooth mineralization (GO:0034505) | 2.69738917 |
| 134 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.67397506 |
| 135 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.63437432 |
| 136 | regulation of monocyte differentiation (GO:0045655) | 2.62192118 |
| 137 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.57852301 |
| 138 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.57384440 |
| 139 | ceramide catabolic process (GO:0046514) | 2.56572100 |
| 140 | oligosaccharide catabolic process (GO:0009313) | 2.55522771 |
| 141 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.55279867 |
| 142 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.55279867 |
| 143 | modulation by symbiont of host immune response (GO:0052553) | 2.55279867 |
| 144 | positive regulation by symbiont of host defense response (GO:0052509) | 2.55279867 |
| 145 | modulation by symbiont of host defense response (GO:0052031) | 2.55279867 |
| 146 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.55279867 |
| 147 | sphingolipid catabolic process (GO:0030149) | 2.55135705 |
| 148 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.54877399 |
| 149 | pinocytosis (GO:0006907) | 2.54768595 |
| 150 | pentose metabolic process (GO:0019321) | 2.53656366 |
| 151 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.53564529 |
| 152 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.52566980 |
| 153 | membrane lipid catabolic process (GO:0046466) | 2.51172768 |
| 154 | pentose-phosphate shunt (GO:0006098) | 2.49412620 |
| 155 | regulation of mononuclear cell migration (GO:0071675) | 2.47929904 |
| 156 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.43370711 |
| 157 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.42076536 |
| 158 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.41571050 |
| 159 | response to muramyl dipeptide (GO:0032495) | 2.40317028 |
| 160 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.39225129 |
| 161 | regulation of tumor necrosis factor production (GO:0032680) | 2.38043431 |
| 162 | positive regulation of histone deacetylation (GO:0031065) | 2.35805362 |
| 163 | autophagic vacuole fusion (GO:0000046) | 2.33951550 |
| 164 | regulation of mast cell activation (GO:0033003) | 2.32161202 |
| 165 | phagosome maturation (GO:0090382) | 2.31228353 |
| 166 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.30937560 |
| 167 | granulocyte activation (GO:0036230) | 2.30882495 |
| 168 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.30668257 |
| 169 | negative regulation of cell killing (GO:0031342) | 2.30668257 |
| 170 | positive regulation of mast cell activation (GO:0033005) | 2.30534704 |
| 171 | positive regulation of hair follicle development (GO:0051798) | 2.29763555 |
| 172 | positive regulation of hair cycle (GO:0042635) | 2.29763555 |
| 173 | proline biosynthetic process (GO:0006561) | 2.29701880 |
| 174 | plasma lipoprotein particle clearance (GO:0034381) | 2.29003416 |
| 175 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.28891571 |
| 176 | regulation of gamma-delta T cell activation (GO:0046643) | 2.28289077 |
| 177 | decidualization (GO:0046697) | 2.26919626 |
| 178 | glucose catabolic process (GO:0006007) | 2.22958305 |
| 179 | positive regulation of cholesterol efflux (GO:0010875) | 2.22126630 |
| 180 | regulation of autophagic vacuole assembly (GO:2000785) | 2.21326817 |
| 181 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.20603927 |
| 182 | glial cell migration (GO:0008347) | 2.20586915 |
| 183 | endothelium development (GO:0003158) | 2.20185538 |
| 184 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.19783657 |
| 185 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.19468482 |
| 186 | negative regulation of cell size (GO:0045792) | 2.19317092 |
| 187 | virion assembly (GO:0019068) | 2.18692247 |
| 188 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.17972664 |
| 189 | negative regulation of innate immune response (GO:0045824) | 2.17242037 |
| 190 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.16680352 |
| 191 | negative regulation of interleukin-6 production (GO:0032715) | 2.16296784 |
| 192 | myeloid dendritic cell differentiation (GO:0043011) | 2.16198725 |
| 193 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.15577408 |
| 194 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.15577408 |
| 195 | tolerance induction (GO:0002507) | 2.14512124 |
| 196 | immunoglobulin mediated immune response (GO:0016064) | 2.14422325 |
| 197 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.14256737 |
| 198 | keratan sulfate catabolic process (GO:0042340) | 2.13803928 |
| 199 | negative regulation of interleukin-2 production (GO:0032703) | 2.13549858 |
| 200 | vacuole organization (GO:0007033) | 2.13084316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.71769132 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.84134820 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.45090787 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.33801945 |
| 5 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.25992023 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.18200128 |
| 7 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.09097456 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.99506323 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.99372921 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.94850782 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.91223629 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.90081229 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.79145424 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.78184084 |
| 15 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.71287458 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.67536823 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.65011081 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.59659287 |
| 19 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.55525002 |
| 20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.53312585 |
| 21 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.39950016 |
| 22 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25012028 |
| 23 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.23757809 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.21044653 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.20085941 |
| 26 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.18154408 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.16448349 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.15334219 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.12169157 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11796087 |
| 31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.11629797 |
| 32 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.09748133 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.09350491 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.07007354 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.06003982 |
| 36 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.03856818 |
| 37 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.02607610 |
| 38 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.02167930 |
| 39 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.01289230 |
| 40 | P68_20966046_ChIP-Seq_HELA_Human | 1.98924596 |
| 41 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.98301036 |
| 42 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.97880608 |
| 43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.97785212 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.94232346 |
| 45 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.93816284 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.93666930 |
| 47 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.92060341 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.84817369 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.82211420 |
| 50 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.78256557 |
| 51 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.77811283 |
| 52 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.77503652 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.77250828 |
| 54 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.76696179 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.75730834 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.75404341 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74817100 |
| 58 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74034414 |
| 59 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.70468644 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.70112646 |
| 61 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.67654660 |
| 62 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66127978 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64576070 |
| 64 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.64471783 |
| 65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.63934322 |
| 66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.63750681 |
| 67 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63201693 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60491700 |
| 69 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.60392415 |
| 70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.59607183 |
| 71 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.59169741 |
| 72 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.59169741 |
| 73 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.59169741 |
| 74 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.53729259 |
| 75 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.53224902 |
| 76 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53117392 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52189109 |
| 78 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.52039399 |
| 79 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.51800299 |
| 80 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.50489530 |
| 81 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.49782218 |
| 82 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.49633308 |
| 83 | MAF_26560356_Chip-Seq_TH1_Human | 1.49475604 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48298084 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48148896 |
| 86 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.47536235 |
| 87 | * MAF_26560356_Chip-Seq_TH2_Human | 1.46562983 |
| 88 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45151484 |
| 89 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.44147983 |
| 90 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43357870 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43141705 |
| 92 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42559259 |
| 93 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42149235 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42042738 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42000452 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40830665 |
| 97 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.40022473 |
| 98 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.39656409 |
| 99 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39260921 |
| 100 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39209069 |
| 101 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.38219117 |
| 102 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.34112389 |
| 103 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33981038 |
| 104 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.32592158 |
| 105 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.31937416 |
| 106 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.30838142 |
| 107 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.30609754 |
| 108 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30379886 |
| 109 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30035711 |
| 110 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.29707069 |
| 111 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.29351577 |
| 112 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29260147 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29245023 |
| 114 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28902319 |
| 115 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.28750129 |
| 116 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28561173 |
| 117 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.27880501 |
| 118 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27665381 |
| 119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27640919 |
| 120 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26384271 |
| 121 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.25782133 |
| 122 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25606500 |
| 123 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24496920 |
| 124 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.24084048 |
| 125 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.24046432 |
| 126 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22678276 |
| 127 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22412686 |
| 128 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22228151 |
| 129 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21834484 |
| 130 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.21147310 |
| 131 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.20903578 |
| 132 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.19486343 |
| 133 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19274913 |
| 134 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.18784685 |
| 135 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17969987 |
| 136 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17719291 |
| 137 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17662218 |
| 138 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17579397 |
| 139 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.17524072 |
| 140 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17376909 |
| 141 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.16997195 |
| 142 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.16882018 |
| 143 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.16841992 |
| 144 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16815039 |
| 145 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16574298 |
| 146 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.16350780 |
| 147 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15894962 |
| 148 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15597692 |
| 149 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.15158687 |
| 150 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13658592 |
| 151 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.13139035 |
| 152 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12722254 |
| 153 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12561990 |
| 154 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11570633 |
| 155 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.11548792 |
| 156 | SA1_27219007_Chip-Seq_Bcells_Human | 1.11389052 |
| 157 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.11279239 |
| 158 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.10842858 |
| 159 | MYC_22102868_ChIP-Seq_BL_Human | 1.10764256 |
| 160 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10177516 |
| 161 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10177509 |
| 162 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.09971873 |
| 163 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.09628621 |
| 164 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09278626 |
| 165 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07016082 |
| 166 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06801399 |
| 167 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06536280 |
| 168 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05388686 |
| 169 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.02636134 |
| 170 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02387141 |
| 171 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.01576180 |
| 172 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.00797611 |
| 173 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.00137801 |
| 174 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.97046502 |
| 175 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.96469893 |
| 176 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.95889841 |
| 177 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94883592 |
| 178 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.94838918 |
| 179 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.94612185 |
| 180 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94415717 |
| 181 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.93899438 |
| 182 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93413901 |
| 183 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.93202731 |
| 184 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92995230 |
| 185 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92627079 |
| 186 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.91442385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.92780471 |
| 2 | MP0003111_abnormal_nucleus_morphology | 4.98287431 |
| 3 | MP0009840_abnormal_foam_cell | 4.34032403 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 4.32617356 |
| 5 | MP0003718_maternal_effect | 3.74044363 |
| 6 | MP0008260_abnormal_autophagy | 3.66534792 |
| 7 | MP0003077_abnormal_cell_cycle | 3.47952734 |
| 8 | MP0010094_abnormal_chromosome_stability | 3.21968573 |
| 9 | MP0003436_decreased_susceptibility_to | 3.03233773 |
| 10 | MP0003303_peritoneal_inflammation | 2.90262756 |
| 11 | MP0001730_embryonic_growth_arrest | 2.75399771 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.59215965 |
| 13 | MP0002653_abnormal_ependyma_morphology | 2.51444612 |
| 14 | MP0002254_reproductive_system_inflammat | 2.37815706 |
| 15 | MP0008058_abnormal_DNA_repair | 2.36950708 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.35278508 |
| 17 | MP0003123_paternal_imprinting | 2.33346814 |
| 18 | MP0003786_premature_aging | 2.30075977 |
| 19 | MP0006082_CNS_inflammation | 2.26838873 |
| 20 | MP0008057_abnormal_DNA_replication | 2.22076373 |
| 21 | MP0001672_abnormal_embryogenesis/_devel | 2.10903522 |
| 22 | MP0005380_embryogenesis_phenotype | 2.10903522 |
| 23 | MP0002419_abnormal_innate_immunity | 2.08468714 |
| 24 | MP0000350_abnormal_cell_proliferation | 2.07297092 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.06662037 |
| 26 | MP0003878_abnormal_ear_physiology | 2.03776418 |
| 27 | MP0005377_hearing/vestibular/ear_phenot | 2.03776418 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.97796200 |
| 29 | MP0003724_increased_susceptibility_to | 1.93081779 |
| 30 | MP0000343_altered_response_to | 1.91499093 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.89699574 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.89322100 |
| 33 | MP0008007_abnormal_cellular_replicative | 1.88458051 |
| 34 | MP0005025_abnormal_response_to | 1.84631315 |
| 35 | MP0001697_abnormal_embryo_size | 1.80369209 |
| 36 | MP0002080_prenatal_lethality | 1.79546507 |
| 37 | MP0003984_embryonic_growth_retardation | 1.78270788 |
| 38 | MP0004510_myositis | 1.76441944 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.74603822 |
| 40 | MP0002139_abnormal_hepatobiliary_system | 1.74054050 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.73088751 |
| 42 | MP0003075_altered_response_to | 1.72789783 |
| 43 | MP0002088_abnormal_embryonic_growth/wei | 1.72615566 |
| 44 | MP0009785_altered_susceptibility_to | 1.71755414 |
| 45 | MP0001661_extended_life_span | 1.69608617 |
| 46 | MP0004858_abnormal_nervous_system | 1.69393076 |
| 47 | MP0003119_abnormal_digestive_system | 1.69097832 |
| 48 | MP0002085_abnormal_embryonic_tissue | 1.67894350 |
| 49 | MP0009764_decreased_sensitivity_to | 1.66365875 |
| 50 | MP0000685_abnormal_immune_system | 1.61245951 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.60292559 |
| 52 | MP0002084_abnormal_developmental_patter | 1.56040851 |
| 53 | MP0005671_abnormal_response_to | 1.54689816 |
| 54 | MP0004947_skin_inflammation | 1.51536944 |
| 55 | MP0005387_immune_system_phenotype | 1.50156486 |
| 56 | MP0001790_abnormal_immune_system | 1.50156486 |
| 57 | MP0003329_amyloid_beta_deposits | 1.49522196 |
| 58 | MP0001542_abnormal_bone_strength | 1.48278729 |
| 59 | MP0002723_abnormal_immune_serum | 1.48037732 |
| 60 | MP0010030_abnormal_orbit_morphology | 1.47800865 |
| 61 | MP0008004_abnormal_stomach_pH | 1.47387969 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.46739903 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.46577558 |
| 64 | MP0002086_abnormal_extraembryonic_tissu | 1.44533846 |
| 65 | MP0000858_altered_metastatic_potential | 1.43112742 |
| 66 | MP0004133_heterotaxia | 1.42155357 |
| 67 | MP0006035_abnormal_mitochondrial_morpho | 1.41593025 |
| 68 | MP0003300_gastrointestinal_ulcer | 1.36117821 |
| 69 | MP0003221_abnormal_cardiomyocyte_apopto | 1.35742740 |
| 70 | MP0001819_abnormal_immune_cell | 1.34698451 |
| 71 | MP0002420_abnormal_adaptive_immunity | 1.34510696 |
| 72 | MP0000358_abnormal_cell_content/ | 1.33221459 |
| 73 | MP0010307_abnormal_tumor_latency | 1.33203345 |
| 74 | MP0005451_abnormal_body_composition | 1.31823495 |
| 75 | MP0003315_abnormal_perineum_morphology | 1.30319014 |
| 76 | MP0000747_muscle_weakness | 1.30204108 |
| 77 | MP0004885_abnormal_endolymph | 1.27051880 |
| 78 | MP0003938_abnormal_ear_development | 1.25148531 |
| 79 | MP0001873_stomach_inflammation | 1.23476724 |
| 80 | MP0001845_abnormal_inflammatory_respons | 1.23357269 |
| 81 | MP0008469_abnormal_protein_level | 1.22544184 |
| 82 | MP0005360_urolithiasis | 1.22000971 |
| 83 | MP0001800_abnormal_humoral_immune | 1.21310501 |
| 84 | MP0002405_respiratory_system_inflammati | 1.20088577 |
| 85 | MP0005390_skeleton_phenotype | 1.14401252 |
| 86 | MP0000313_abnormal_cell_death | 1.14252849 |
| 87 | MP0010155_abnormal_intestine_physiology | 1.13944069 |
| 88 | MP0004381_abnormal_hair_follicle | 1.13792375 |
| 89 | MP0002132_abnormal_respiratory_system | 1.13650102 |
| 90 | MP0005395_other_phenotype | 1.12629915 |
| 91 | MP0005332_abnormal_amino_acid | 1.12446792 |
| 92 | MP0004019_abnormal_vitamin_homeostasis | 1.11667368 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 1.11625267 |
| 94 | MP0003567_abnormal_fetal_cardiomyocyte | 1.11540278 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 1.08997274 |
| 96 | MP0003763_abnormal_thymus_physiology | 1.08246737 |
| 97 | MP0001853_heart_inflammation | 1.07551752 |
| 98 | MP0003279_aneurysm | 1.06784428 |
| 99 | MP0002269_muscular_atrophy | 1.06115622 |
| 100 | MP0006054_spinal_hemorrhage | 1.04844684 |
| 101 | MP0005384_cellular_phenotype | 1.01651197 |
| 102 | MP0009672_abnormal_birth_weight | 1.00848739 |
| 103 | MP0000716_abnormal_immune_system | 1.00171190 |
| 104 | MP0004197_abnormal_fetal_growth/weight/ | 0.99571181 |
| 105 | MP0000465_gastrointestinal_hemorrhage | 0.98605272 |
| 106 | MP0002877_abnormal_melanocyte_morpholog | 0.98566145 |
| 107 | MP0005365_abnormal_bile_salt | 0.98252640 |
| 108 | MP0000428_abnormal_craniofacial_morphol | 0.98052799 |
| 109 | MP0005621_abnormal_cell_physiology | 0.97693940 |
| 110 | MP0002111_abnormal_tail_morphology | 0.95495374 |
| 111 | MP0000750_abnormal_muscle_regeneration | 0.95352958 |
| 112 | MP0001145_abnormal_male_reproductive | 0.94687994 |
| 113 | MP0000681_abnormal_thyroid_gland | 0.94434916 |
| 114 | MP0003890_abnormal_embryonic-extraembry | 0.93263747 |
| 115 | MP0008438_abnormal_cutaneous_collagen | 0.89904781 |
| 116 | MP0008877_abnormal_DNA_methylation | 0.89686227 |
| 117 | MP0002429_abnormal_blood_cell | 0.89493670 |
| 118 | MP0001756_abnormal_urination | 0.88738126 |
| 119 | MP0002210_abnormal_sex_determination | 0.86121176 |
| 120 | MP0003795_abnormal_bone_structure | 0.83847732 |
| 121 | MP0002160_abnormal_reproductive_system | 0.83346257 |
| 122 | MP0003191_abnormal_cellular_cholesterol | 0.82932813 |
| 123 | MP0002398_abnormal_bone_marrow | 0.82159256 |
| 124 | MP0000537_abnormal_urethra_morphology | 0.81601159 |
| 125 | MP0001849_ear_inflammation | 0.81393809 |
| 126 | MP0003879_abnormal_hair_cell | 0.79636774 |
| 127 | MP0003172_abnormal_lysosome_physiology | 0.79597662 |
| 128 | MP0002722_abnormal_immune_system | 0.79159288 |
| 129 | MP0001764_abnormal_homeostasis | 0.78749784 |
| 130 | MP0005076_abnormal_cell_differentiation | 0.78746406 |
| 131 | MP0001293_anophthalmia | 0.78738037 |
| 132 | MP0000689_abnormal_spleen_morphology | 0.78382612 |
| 133 | MP0005166_decreased_susceptibility_to | 0.77932621 |
| 134 | MP0001663_abnormal_digestive_system | 0.76977921 |
| 135 | MP0005595_abnormal_vascular_smooth | 0.76849598 |
| 136 | MP0002933_joint_inflammation | 0.76601648 |
| 137 | MP0002127_abnormal_cardiovascular_syste | 0.75579534 |
| 138 | MP0005410_abnormal_fertilization | 0.75413141 |
| 139 | MP0005310_abnormal_salivary_gland | 0.74809644 |
| 140 | MP0003828_pulmonary_edema | 0.74757439 |
| 141 | MP0005319_abnormal_enzyme/_coenzyme | 0.74654184 |
| 142 | MP0003705_abnormal_hypodermis_morpholog | 0.74032559 |
| 143 | MP0003186_abnormal_redox_activity | 0.74004929 |
| 144 | MP0009703_decreased_birth_body | 0.73487988 |
| 145 | MP0000015_abnormal_ear_pigmentation | 0.73451699 |
| 146 | MP0009278_abnormal_bone_marrow | 0.73357867 |
| 147 | MP0000490_abnormal_crypts_of | 0.73056484 |
| 148 | MP0003448_altered_tumor_morphology | 0.72946649 |
| 149 | MP0005647_abnormal_sex_gland | 0.72899601 |
| 150 | MP0004233_abnormal_muscle_weight | 0.72606162 |
| 151 | MP0004264_abnormal_extraembryonic_tissu | 0.71139010 |
| 152 | MP0005165_increased_susceptibility_to | 0.69967872 |
| 153 | MP0003941_abnormal_skin_development | 0.69528969 |
| 154 | MP0003183_abnormal_peptide_metabolism | 0.68346576 |
| 155 | MP0003646_muscle_fatigue | 0.68103738 |
| 156 | MP0003632_abnormal_nervous_system | 0.67880453 |
| 157 | MP0000653_abnormal_sex_gland | 0.67795351 |
| 158 | MP0002138_abnormal_hepatobiliary_system | 0.67655069 |
| 159 | MP0003937_abnormal_limbs/digits/tail_de | 0.67421712 |
| 160 | MP0000609_abnormal_liver_physiology | 0.67366212 |
| 161 | MP0003936_abnormal_reproductive_system | 0.66823898 |
| 162 | MP0001545_abnormal_hematopoietic_system | 0.66792615 |
| 163 | MP0005397_hematopoietic_system_phenotyp | 0.66792615 |
| 164 | MP0001929_abnormal_gametogenesis | 0.66165754 |
| 165 | MP0002019_abnormal_tumor_incidence | 0.66132154 |
| 166 | MP0010368_abnormal_lymphatic_system | 0.65827447 |
| 167 | MP0002092_abnormal_eye_morphology | 0.60634265 |
| 168 | MP0004084_abnormal_cardiac_muscle | 0.60135026 |
| 169 | MP0003861_abnormal_nervous_system | 0.59352093 |
| 170 | MP0006036_abnormal_mitochondrial_physio | 0.59061263 |
| 171 | MP0003136_yellow_coat_color | 0.58723849 |
| 172 | MP0003699_abnormal_female_reproductive | 0.58051906 |
| 173 | MP0005075_abnormal_melanosome_morpholog | 0.57510370 |
| 174 | MP0003283_abnormal_digestive_organ | 0.56282848 |
| 175 | MP0002161_abnormal_fertility/fecundity | 0.54299720 |
| 176 | MP0000604_amyloidosis | 0.53163532 |
| 177 | MP0002796_impaired_skin_barrier | 0.52034773 |
| 178 | MP0003656_abnormal_erythrocyte_physiolo | 0.51693559 |
| 179 | MP0003634_abnormal_glial_cell | 0.51483339 |
| 180 | MP0000627_abnormal_mammary_gland | 0.51245808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 6.12960972 |
| 2 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.72759160 |
| 3 | Breast hypoplasia (HP:0003187) | 5.49568118 |
| 4 | Cerebral hypomyelination (HP:0006808) | 5.19800669 |
| 5 | Dysostosis multiplex (HP:0000943) | 5.10305717 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.98792782 |
| 7 | Birth length less than 3rd percentile (HP:0003561) | 4.89263073 |
| 8 | Carpal bone hypoplasia (HP:0001498) | 4.47394045 |
| 9 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.33839814 |
| 10 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.33839814 |
| 11 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.33839814 |
| 12 | Rough bone trabeculation (HP:0100670) | 4.22515157 |
| 13 | Hyperglycinemia (HP:0002154) | 4.19266017 |
| 14 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.03261012 |
| 15 | Loss of speech (HP:0002371) | 3.87117299 |
| 16 | Mucopolysacchariduria (HP:0008155) | 3.86961961 |
| 17 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.86961961 |
| 18 | Abnormality of the umbilical cord (HP:0010881) | 3.67963870 |
| 19 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.65538004 |
| 20 | Increased serum ferritin (HP:0003281) | 3.64009049 |
| 21 | Absent radius (HP:0003974) | 3.52432862 |
| 22 | Hyperglycinuria (HP:0003108) | 3.50702975 |
| 23 | Ureteral duplication (HP:0000073) | 3.50199821 |
| 24 | Patellar aplasia (HP:0006443) | 3.49497370 |
| 25 | Impulsivity (HP:0100710) | 3.49392319 |
| 26 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.44405442 |
| 27 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.43829710 |
| 28 | J-shaped sella turcica (HP:0002680) | 3.40354354 |
| 29 | Abnormality of macrophages (HP:0004311) | 3.38645878 |
| 30 | Aplasia involving forearm bones (HP:0009822) | 3.33639031 |
| 31 | Absent forearm bone (HP:0003953) | 3.33639031 |
| 32 | Gout (HP:0001997) | 3.29132575 |
| 33 | Petechiae (HP:0000967) | 3.27144082 |
| 34 | Systemic lupus erythematosus (HP:0002725) | 3.17078207 |
| 35 | Abnormality of the labia minora (HP:0012880) | 3.14770192 |
| 36 | Premature ovarian failure (HP:0008209) | 3.07802818 |
| 37 | Abnormality of iron homeostasis (HP:0011031) | 3.07686335 |
| 38 | Thoracic kyphosis (HP:0002942) | 3.07083470 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 3.05517946 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.05517946 |
| 41 | Abnormal trabecular bone morphology (HP:0100671) | 3.05149800 |
| 42 | Progressive muscle weakness (HP:0003323) | 3.03299147 |
| 43 | Megaloblastic anemia (HP:0001889) | 3.03083019 |
| 44 | Degeneration of anterior horn cells (HP:0002398) | 2.96094000 |
| 45 | Abnormality of the anterior horn cell (HP:0006802) | 2.96094000 |
| 46 | CNS hypomyelination (HP:0003429) | 2.89703047 |
| 47 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.89628812 |
| 48 | Purpura (HP:0000979) | 2.86652694 |
| 49 | Premature rupture of membranes (HP:0001788) | 2.81520641 |
| 50 | Multiple enchondromatosis (HP:0005701) | 2.79567236 |
| 51 | Stomatitis (HP:0010280) | 2.78406634 |
| 52 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.76200374 |
| 53 | Personality changes (HP:0000751) | 2.68845468 |
| 54 | Vertebral compression fractures (HP:0002953) | 2.68401894 |
| 55 | Delusions (HP:0000746) | 2.64736571 |
| 56 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.64421006 |
| 57 | Death in infancy (HP:0001522) | 2.61938489 |
| 58 | Abnormality of the thoracic spine (HP:0100711) | 2.61178440 |
| 59 | Eczematoid dermatitis (HP:0000976) | 2.57133912 |
| 60 | Axonal loss (HP:0003447) | 2.57126579 |
| 61 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.56193747 |
| 62 | Nuclear cataract (HP:0100018) | 2.54234728 |
| 63 | Secondary amenorrhea (HP:0000869) | 2.53820912 |
| 64 | Spinal muscular atrophy (HP:0007269) | 2.52342587 |
| 65 | Trismus (HP:0000211) | 2.50452531 |
| 66 | Ependymoma (HP:0002888) | 2.49911351 |
| 67 | Split foot (HP:0001839) | 2.44945803 |
| 68 | Autoimmune thrombocytopenia (HP:0001973) | 2.44034104 |
| 69 | Microretrognathia (HP:0000308) | 2.43603876 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.43323444 |
| 71 | Breast aplasia (HP:0100783) | 2.42173184 |
| 72 | Ankle contracture (HP:0006466) | 2.42053866 |
| 73 | Tetraplegia (HP:0002445) | 2.37990268 |
| 74 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.37611826 |
| 75 | Dysautonomia (HP:0002459) | 2.36384286 |
| 76 | Prolonged neonatal jaundice (HP:0006579) | 2.35453711 |
| 77 | Absent thumb (HP:0009777) | 2.30889487 |
| 78 | Postnatal microcephaly (HP:0005484) | 2.29664175 |
| 79 | Joint stiffness (HP:0001387) | 2.29643691 |
| 80 | Oral leukoplakia (HP:0002745) | 2.28756310 |
| 81 | Progressive neurologic deterioration (HP:0002344) | 2.28713719 |
| 82 | Sparse eyelashes (HP:0000653) | 2.28183460 |
| 83 | Entropion (HP:0000621) | 2.27370556 |
| 84 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25373795 |
| 85 | Cervical subluxation (HP:0003308) | 2.25092111 |
| 86 | CNS demyelination (HP:0007305) | 2.24978657 |
| 87 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24129760 |
| 88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24129760 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24129760 |
| 90 | Abnormal neuron morphology (HP:0012757) | 2.24049518 |
| 91 | Abnormality of the motor neurons (HP:0002450) | 2.24049518 |
| 92 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 2.22620244 |
| 93 | Prolonged bleeding time (HP:0003010) | 2.22564799 |
| 94 | Recurrent abscess formation (HP:0002722) | 2.21861616 |
| 95 | Myositis (HP:0100614) | 2.20327771 |
| 96 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.19346081 |
| 97 | Single umbilical artery (HP:0001195) | 2.19346081 |
| 98 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.19346081 |
| 99 | Retinal atrophy (HP:0001105) | 2.19077429 |
| 100 | Sparse lateral eyebrow (HP:0005338) | 2.18942872 |
| 101 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.17953495 |
| 102 | Patent foramen ovale (HP:0001655) | 2.17499659 |
| 103 | Global brain atrophy (HP:0002283) | 2.17022458 |
| 104 | Recurrent bacterial skin infections (HP:0005406) | 2.16492504 |
| 105 | Short clavicles (HP:0000894) | 2.15853284 |
| 106 | Abnormality of serum amino acid levels (HP:0003112) | 2.14000358 |
| 107 | Amyotrophic lateral sclerosis (HP:0007354) | 2.13625684 |
| 108 | Absent hand (HP:0004050) | 2.12237731 |
| 109 | Horseshoe kidney (HP:0000085) | 2.11935955 |
| 110 | Xanthomatosis (HP:0000991) | 2.11916824 |
| 111 | Mesangial abnormality (HP:0001966) | 2.11736311 |
| 112 | Selective tooth agenesis (HP:0001592) | 2.10936304 |
| 113 | Reticulocytosis (HP:0001923) | 2.10887238 |
| 114 | Mutism (HP:0002300) | 2.08108440 |
| 115 | Stridor (HP:0010307) | 2.07758792 |
| 116 | Diminished motivation (HP:0000745) | 2.07451960 |
| 117 | Oligodactyly (HP:0012165) | 2.07131425 |
| 118 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.06804124 |
| 119 | Mediastinal lymphadenopathy (HP:0100721) | 2.05127368 |
| 120 | Obstructive lung disease (HP:0006536) | 2.04406913 |
| 121 | Chronic obstructive pulmonary disease (HP:0006510) | 2.04406913 |
| 122 | Bone marrow hypocellularity (HP:0005528) | 2.04385835 |
| 123 | Short humerus (HP:0005792) | 2.01868220 |
| 124 | Restlessness (HP:0000711) | 2.00828717 |
| 125 | Cardiomegaly (HP:0001640) | 2.00808398 |
| 126 | Achilles tendon contracture (HP:0001771) | 1.99865252 |
| 127 | Abnormality of lateral ventricle (HP:0030047) | 1.98524186 |
| 128 | Neurofibrillary tangles (HP:0002185) | 1.98353905 |
| 129 | Meckel diverticulum (HP:0002245) | 1.98313115 |
| 130 | Pustule (HP:0200039) | 1.97636753 |
| 131 | Clumsiness (HP:0002312) | 1.96082261 |
| 132 | Myocardial infarction (HP:0001658) | 1.95567034 |
| 133 | Abnormality of the ileum (HP:0001549) | 1.93039251 |
| 134 | Glossoptosis (HP:0000162) | 1.92566424 |
| 135 | Hemorrhage of the eye (HP:0011885) | 1.91595324 |
| 136 | Distal upper limb amyotrophy (HP:0007149) | 1.91410930 |
| 137 | Upper limb amyotrophy (HP:0009129) | 1.91410930 |
| 138 | Irregular epiphyses (HP:0010582) | 1.91032194 |
| 139 | Anal stenosis (HP:0002025) | 1.88023037 |
| 140 | Orchitis (HP:0100796) | 1.87792555 |
| 141 | Neuronal loss in central nervous system (HP:0002529) | 1.87719601 |
| 142 | Diaphragmatic weakness (HP:0009113) | 1.87364651 |
| 143 | Abnormality of the Achilles tendon (HP:0005109) | 1.87138056 |
| 144 | Neoplasm of the pancreas (HP:0002894) | 1.86967028 |
| 145 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.86750179 |
| 146 | Nonimmune hydrops fetalis (HP:0001790) | 1.86166350 |
| 147 | Apathy (HP:0000741) | 1.85342088 |
| 148 | Emotional lability (HP:0000712) | 1.85276443 |
| 149 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.85266008 |
| 150 | Shawl scrotum (HP:0000049) | 1.84047648 |
| 151 | Adactyly (HP:0009776) | 1.83873562 |
| 152 | Hyperacusis (HP:0010780) | 1.83614843 |
| 153 | Amyloidosis (HP:0011034) | 1.82975251 |
| 154 | Atrioventricular block (HP:0001678) | 1.82840688 |
| 155 | Oligodactyly (hands) (HP:0001180) | 1.82034244 |
| 156 | Spastic paraparesis (HP:0002313) | 1.81224085 |
| 157 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.79647943 |
| 158 | Absent epiphyses (HP:0010577) | 1.79647943 |
| 159 | Stillbirth (HP:0003826) | 1.79219411 |
| 160 | Hematochezia (HP:0002573) | 1.78196314 |
| 161 | Epistaxis (HP:0000421) | 1.78148635 |
| 162 | Testicular atrophy (HP:0000029) | 1.77882733 |
| 163 | Premature graying of hair (HP:0002216) | 1.75767902 |
| 164 | Dementia (HP:0000726) | 1.75488731 |
| 165 | Macrocytic anemia (HP:0001972) | 1.75430705 |
| 166 | Bulbar palsy (HP:0001283) | 1.75008361 |
| 167 | Disinhibition (HP:0000734) | 1.74558249 |
| 168 | Shoulder girdle muscle weakness (HP:0003547) | 1.74422154 |
| 169 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.73996951 |
| 170 | Asymmetric septal hypertrophy (HP:0001670) | 1.73866863 |
| 171 | Cerebral aneurysm (HP:0004944) | 1.70321520 |
| 172 | Recurrent fungal infections (HP:0002841) | 1.66316668 |
| 173 | Upper motor neuron abnormality (HP:0002127) | 1.65969077 |
| 174 | Deformed sella turcica (HP:0002681) | 1.65861134 |
| 175 | Hypertriglyceridemia (HP:0002155) | 1.64643190 |
| 176 | Easy fatigability (HP:0003388) | 1.62034007 |
| 177 | Thin bony cortex (HP:0002753) | 1.60992559 |
| 178 | Polycythemia (HP:0001901) | 1.60023186 |
| 179 | Increased IgM level (HP:0003496) | 1.59814518 |
| 180 | Ragged-red muscle fibers (HP:0003200) | 1.58886381 |
| 181 | Glomerulonephritis (HP:0000099) | 1.57844384 |
| 182 | Impaired platelet aggregation (HP:0003540) | 1.54644297 |
| 183 | Abnormal platelet function (HP:0011869) | 1.54644297 |
| 184 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.53193136 |
| 185 | Spinal rigidity (HP:0003306) | 1.53173470 |
| 186 | Elevated alkaline phosphatase (HP:0003155) | 1.52630869 |
| 187 | Opisthotonus (HP:0002179) | 1.52185362 |
| 188 | Premature skin wrinkling (HP:0100678) | 1.51545722 |
| 189 | Paraparesis (HP:0002385) | 1.51373562 |
| 190 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.51156235 |
| 191 | Long toe (HP:0010511) | 1.51057667 |
| 192 | Flat capital femoral epiphysis (HP:0003370) | 1.50916017 |
| 193 | Hypertensive crisis (HP:0100735) | 1.50844189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 7.07571623 |
| 2 | WEE1 | 4.02088384 |
| 3 | AKT3 | 3.83617017 |
| 4 | EPHA2 | 3.58469873 |
| 5 | TSSK6 | 3.45084469 |
| 6 | ERN1 | 3.38886595 |
| 7 | NEK2 | 2.88594873 |
| 8 | TRIB3 | 2.72731673 |
| 9 | SIK1 | 2.53535900 |
| 10 | ARAF | 2.46088795 |
| 11 | NEK1 | 2.45568861 |
| 12 | PLK4 | 2.32033341 |
| 13 | STK16 | 2.20017730 |
| 14 | TTK | 2.19519804 |
| 15 | EIF2AK1 | 2.19168082 |
| 16 | SMG1 | 2.01328449 |
| 17 | MAP4K1 | 1.92989042 |
| 18 | BRAF | 1.91665551 |
| 19 | TESK1 | 1.87983280 |
| 20 | TIE1 | 1.83208098 |
| 21 | LATS2 | 1.82766046 |
| 22 | PLK1 | 1.81994627 |
| 23 | RIPK4 | 1.81736453 |
| 24 | PNCK | 1.79327210 |
| 25 | MAP2K3 | 1.78692858 |
| 26 | MARK3 | 1.74825423 |
| 27 | TBK1 | 1.74608950 |
| 28 | ICK | 1.69915030 |
| 29 | TESK2 | 1.67113660 |
| 30 | SRPK1 | 1.65605325 |
| 31 | DYRK3 | 1.59639130 |
| 32 | PLK3 | 1.56722799 |
| 33 | NME2 | 1.50165224 |
| 34 | PIM2 | 1.49968343 |
| 35 | MATK | 1.46864141 |
| 36 | MAPKAPK3 | 1.42363550 |
| 37 | STK38L | 1.39645184 |
| 38 | ZAP70 | 1.39275589 |
| 39 | SIK3 | 1.33642542 |
| 40 | CDC42BPA | 1.31474169 |
| 41 | CHEK2 | 1.29297002 |
| 42 | IRAK4 | 1.27894186 |
| 43 | IKBKB | 1.22106219 |
| 44 | EPHB1 | 1.21948998 |
| 45 | PAK4 | 1.21430220 |
| 46 | EEF2K | 1.20935816 |
| 47 | MAP3K1 | 1.20616387 |
| 48 | KDR | 1.18941309 |
| 49 | SIK2 | 1.18845078 |
| 50 | AURKA | 1.17824802 |
| 51 | TGFBR2 | 1.15833102 |
| 52 | CDK7 | 1.14870346 |
| 53 | BRSK1 | 1.13726123 |
| 54 | BRSK2 | 1.12597251 |
| 55 | PRKCI | 1.11895026 |
| 56 | CDC7 | 1.11430885 |
| 57 | ZAK | 1.10597388 |
| 58 | TAOK1 | 1.08026349 |
| 59 | EIF2AK3 | 1.02580708 |
| 60 | MAP3K8 | 1.01298689 |
| 61 | MAP3K9 | 1.00931753 |
| 62 | PINK1 | 0.99235933 |
| 63 | GRK7 | 0.99106509 |
| 64 | ALK | 0.98826016 |
| 65 | MAP3K11 | 0.98737317 |
| 66 | ADRBK2 | 0.98037951 |
| 67 | BLK | 0.97422645 |
| 68 | AURKB | 0.97357805 |
| 69 | JAK3 | 0.95686046 |
| 70 | CCNB1 | 0.95460726 |
| 71 | BTK | 0.93363070 |
| 72 | TLK1 | 0.92152968 |
| 73 | BCKDK | 0.90278798 |
| 74 | ACVR1B | 0.90240708 |
| 75 | TNK2 | 0.89975721 |
| 76 | PAK1 | 0.89847731 |
| 77 | PDK2 | 0.89362033 |
| 78 | PRKD2 | 0.88065330 |
| 79 | CHEK1 | 0.85262486 |
| 80 | RPS6KA2 | 0.84549003 |
| 81 | PDK3 | 0.84103447 |
| 82 | PDK4 | 0.84103447 |
| 83 | TYK2 | 0.84002460 |
| 84 | BMX | 0.80144913 |
| 85 | CDK4 | 0.79786242 |
| 86 | RPS6KC1 | 0.79711921 |
| 87 | RPS6KL1 | 0.79711921 |
| 88 | VRK2 | 0.79238662 |
| 89 | CDK12 | 0.76571334 |
| 90 | MAP3K14 | 0.76057328 |
| 91 | RPS6KA6 | 0.75440103 |
| 92 | LIMK1 | 0.75105741 |
| 93 | PDPK1 | 0.75000689 |
| 94 | IRAK2 | 0.74963090 |
| 95 | PKN2 | 0.74629664 |
| 96 | CSK | 0.74374807 |
| 97 | HIPK2 | 0.73894946 |
| 98 | TTN | 0.73350498 |
| 99 | CSNK1G3 | 0.73237696 |
| 100 | FES | 0.71716950 |
| 101 | CDK2 | 0.69484959 |
| 102 | IKBKE | 0.69475841 |
| 103 | IRAK3 | 0.69091844 |
| 104 | TXK | 0.68932277 |
| 105 | RIPK1 | 0.67150066 |
| 106 | DYRK2 | 0.65874200 |
| 107 | NME1 | 0.65695714 |
| 108 | RPS6KA4 | 0.65196574 |
| 109 | ATR | 0.63903163 |
| 110 | TAOK2 | 0.63578791 |
| 111 | MOS | 0.63508901 |
| 112 | MARK2 | 0.62947661 |
| 113 | PRKG2 | 0.62131155 |
| 114 | CSNK1E | 0.61020599 |
| 115 | STK38 | 0.60351160 |
| 116 | MAP2K2 | 0.59422725 |
| 117 | MTOR | 0.59001212 |
| 118 | KIT | 0.58934372 |
| 119 | CHUK | 0.58642596 |
| 120 | HCK | 0.58506116 |
| 121 | AKT2 | 0.58186567 |
| 122 | PRPF4B | 0.57975098 |
| 123 | RPS6KB2 | 0.57943423 |
| 124 | STK3 | 0.56131998 |
| 125 | VRK1 | 0.56076712 |
| 126 | FGR | 0.54883271 |
| 127 | MAP3K13 | 0.51470892 |
| 128 | SYK | 0.51076624 |
| 129 | RAF1 | 0.51002623 |
| 130 | IRAK1 | 0.49855786 |
| 131 | CSNK2A2 | 0.49819456 |
| 132 | MAP2K6 | 0.49618105 |
| 133 | FGFR4 | 0.46217772 |
| 134 | MKNK1 | 0.46047392 |
| 135 | PIM1 | 0.45732159 |
| 136 | CDK1 | 0.45456146 |
| 137 | MAP3K7 | 0.45433169 |
| 138 | GRK6 | 0.45370103 |
| 139 | CSF1R | 0.45311210 |
| 140 | TAOK3 | 0.44525187 |
| 141 | STK10 | 0.43832797 |
| 142 | PAK6 | 0.43594561 |
| 143 | MAP3K3 | 0.42372734 |
| 144 | LYN | 0.41545249 |
| 145 | MKNK2 | 0.41301079 |
| 146 | MAPKAPK2 | 0.41004647 |
| 147 | CSNK2A1 | 0.40706658 |
| 148 | MARK1 | 0.40635960 |
| 149 | CSNK1A1L | 0.40273250 |
| 150 | MAP3K5 | 0.39966235 |
| 151 | DYRK1B | 0.39304422 |
| 152 | LCK | 0.38934684 |
| 153 | CSNK1G1 | 0.38152872 |
| 154 | CSNK1G2 | 0.37530585 |
| 155 | DDR2 | 0.35544052 |
| 156 | RPS6KA5 | 0.33188475 |
| 157 | ABL2 | 0.32429785 |
| 158 | PRKCG | 0.30022669 |
| 159 | PRKAA1 | 0.29243063 |
| 160 | DAPK3 | 0.28628193 |
| 161 | TYRO3 | 0.26945948 |
| 162 | ATM | 0.26750694 |
| 163 | CSNK1A1 | 0.22981242 |
| 164 | MAPK11 | 0.22666841 |
| 165 | CDK11A | 0.22495418 |
| 166 | MAPK10 | 0.21325247 |
| 167 | DAPK1 | 0.21214141 |
| 168 | CDK14 | 0.21063078 |
| 169 | CDK15 | 0.20212896 |
| 170 | STK4 | 0.19552759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.41060288 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.51983849 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 4.34399638 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 4.20467391 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.76611516 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 3.15508307 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 3.02488920 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 2.80648546 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.64443677 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.52085033 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.31767230 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.31323563 |
| 13 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.26659162 |
| 14 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.23578093 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.22158332 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 2.19656892 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.10024749 |
| 18 | Cell cycle_Homo sapiens_hsa04110 | 2.04075338 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.90522480 |
| 20 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.87790223 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.85903927 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.84092438 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.83889990 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.83118114 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.79679568 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.79120637 |
| 27 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.76848455 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.75097447 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.72025005 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.67171390 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.67130070 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64677517 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.64531697 |
| 34 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.64004881 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.55822656 |
| 36 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.54654944 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.54554445 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.52725561 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50569898 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49267175 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48156850 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.48137567 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.47752727 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.47595503 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.46965740 |
| 46 | Purine metabolism_Homo sapiens_hsa00230 | 1.44091513 |
| 47 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.43732138 |
| 48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.42514758 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.33230231 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.32337963 |
| 51 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.31056149 |
| 52 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.30599676 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28167343 |
| 54 | Allograft rejection_Homo sapiens_hsa05330 | 1.27894020 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19931667 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.19684342 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 1.13261847 |
| 58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.11981378 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 1.09309031 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06618238 |
| 61 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06163280 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05802004 |
| 63 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.05116142 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01745865 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.00867650 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00812768 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00772255 |
| 68 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.98885386 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96753478 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96712045 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.96326041 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.94462326 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.93117393 |
| 74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91792594 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90937280 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.86418048 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85638917 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84804876 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84033673 |
| 80 | RNA degradation_Homo sapiens_hsa03018 | 0.83500420 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82392852 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.82385257 |
| 83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82000606 |
| 84 | Shigellosis_Homo sapiens_hsa05131 | 0.81942261 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.79345605 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.79104134 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76799874 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.74828727 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74819902 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74630962 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74105779 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72403767 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72389492 |
| 94 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71665824 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70519984 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69602222 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67993905 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66393991 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65126348 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62683349 |
| 101 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62365682 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60524820 |
| 103 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58940477 |
| 104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57793368 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56550591 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55968375 |
| 107 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54969642 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54298097 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.53351295 |
| 110 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53240317 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.50891256 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49657442 |
| 113 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48893809 |
| 114 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47978221 |
| 115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47825190 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47633738 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46547289 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46336061 |
| 119 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46169550 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46062718 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.44968348 |
| 122 | Measles_Homo sapiens_hsa05162 | 0.44221178 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41758247 |
| 124 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39330547 |
| 125 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39194146 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38269182 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37261196 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.35552509 |
| 129 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35088496 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34950787 |
| 131 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.33611229 |
| 132 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33175474 |
| 133 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.32451824 |
| 134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31024160 |
| 135 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29363759 |
| 136 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.27936655 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27740465 |
| 138 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27157982 |
| 139 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25443520 |
| 140 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.22114794 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.20300837 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.19470131 |
| 143 | Tight junction_Homo sapiens_hsa04530 | 0.19172859 |
| 144 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.18239384 |
| 145 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.16886953 |
| 146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16216782 |
| 147 | Huntingtons disease_Homo sapiens_hsa05016 | 0.15808908 |
| 148 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.15754659 |
| 149 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.15650879 |
| 150 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13665509 |
| 151 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12808950 |
| 152 | HTLV-I infection_Homo sapiens_hsa05166 | 0.11614083 |
| 153 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.11210904 |
| 154 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.11086648 |
| 155 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.10548058 |
| 156 | Bladder cancer_Homo sapiens_hsa05219 | 0.10435089 |
| 157 | Thyroid cancer_Homo sapiens_hsa05216 | 0.10399908 |
| 158 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.10371085 |
| 159 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.10117810 |
| 160 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.09279035 |
| 161 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07779489 |
| 162 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.05772580 |
| 163 | Endocytosis_Homo sapiens_hsa04144 | 0.05633434 |
| 164 | Apoptosis_Homo sapiens_hsa04210 | 0.05415934 |
| 165 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.04042838 |
| 166 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.03652410 |
| 167 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.02700326 |
| 168 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.01557005 |
| 169 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.01395758 |

